Short Interest in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) Increases By 480.0%

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) saw a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 2,900 shares, a growth of 480.0% from the September 30th total of 500 shares. Based on an average daily volume of 26,700 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 26,700 shares, the days-to-cover ratio is currently 0.1 days.

Rocket Pharmaceuticals Stock Down 4.1%

Shares of Rocket Pharmaceuticals stock opened at $0.04 on Tuesday. The firm’s 50 day moving average is $0.04 and its 200 day moving average is $0.04. Rocket Pharmaceuticals has a 1 year low of $0.02 and a 1 year high of $0.10.

Rocket Pharmaceuticals Company Profile

Rocket Pharmaceuticals, Inc, together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.